Claret Asset Management Corp Amgen Inc Transaction History

Claret Asset Management Corp

$611 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $1.28 Million - $1.46 Million	-6,426 Closed	0 $0
Q3 2021 Dec 02, 2021	BUY	$212.27 - $248.7 $43,939 - $51,480	207 Added 3.33%	6,426 $1.37 Million
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $8,654 - $10,085	39 Added 0.63%	6,219 $1.55 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $22,070 - $26,282	-102 Reduced 1.62%	6,180 $1.42 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $51,857 - $57,669	-221 Reduced 3.4%	6,282 $1.6 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $74,376 - $91,270	-376 Reduced 5.47%	6,503 $1.53 Million
Q1 2020 Apr 06, 2020	SELL	$182.24 - $241.7 $10,387 - $13,776	-57 Reduced 0.82%	6,879 $1.4 Million
Q4 2019 Jan 07, 2020	SELL	$189.21 - $243.2 $22,705 - $29,184	-120 Reduced 1.7%	6,936 $1.67 Million
Q3 2019 Oct 11, 2019	SELL	$174.11 - $208.62 $16,366 - $19,610	-94 Reduced 1.31%	7,056 $1.37 Million
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $2,667 - $3,126	16 Added 0.22%	7,150 $1.32 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $45,760 - $51,581	-253 Reduced 3.42%	7,134 $1.36 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $45,670 - $53,312	-256 Reduced 3.35%	7,387 $1.44 Million
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $20,196 - $22,769	-109 Reduced 1.41%	7,643 $1.58 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $37,859 - $42,524	228 Added 3.03%	7,752 $1.43 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $677 - $792	-4 Reduced 0.05%	7,524 $1.28 Million
Q4 2017 Mar 27, 2018	BUY	$168.79 - $188.59 $1.27 Million - $1.42 Million	7,528	7,528 $1.31 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Account